Summary.-2-Acetylaminofluorene induced mammary and ear duct carcinomata and spontaneously arising mammary carcinomata and sarcomata were shown to express embryonic antigens at the cell surface by their reaction with serum from multiparous female rats. These observations with essentially non-immunogenic tumours are comparable with early findings showing that embryonic antigens are also expressed on aminoazo dye induced rat hepatomata, and sarcomata induced with 3-methylcholanthrene. Re-expression of embryonal components, therefore, may be a concomitant of neoplastic transformation.
THE CONCEPT that malignant cells re-express embryonal characteristics has gained considerable support from recent studies showing that experimental animal tumours induced by oncogenic viruses or chemical carcinogens exhibit tumour associated embryonic antigens (Alexander, 1972; Baldwin, 1973) . The appearance of so-called " oncofoetal " antigens on human tumours is also exemplified by x-foetoprotein associated with hepatocellular carcinoma and carcinoembryonic antioen associated with malignancies of the gastrointestinal tract (Laurence and Neville, 1972) .
These observations suggest that reexpression of embryonal components may be a feature of many, if not all, malignant cells and furthermore raises the possibility that the tumour rejection antigens demonstrable on experimental animal tumours (Deichman, 1969; Pasternak, 1969; Baldwin, 1973 ) may be identified as embryonic antigens. These postulates have been analysed comprehensively using a range of immunogenic rat tumours including 3-methyleholanthrene (Mc) induced sarcomata and 4-dimethylaminoazobenzene (DAB) induced hepotomata maintained by transplantation in syngeneic Wistar rats (Baldwin, Glaves and Pimm, 1971;  Baldwin et al., 1 972a; Baldwin, Glaves and Vose, 1972b; Baldwin et al., 1974a) . From these studies it was concluded that embryonic antigen expression was a concomitant of malignant change, although it was possible to differentiate between these antigens and the tumour rejection antigens by their specificities (Baldwin et al., 1972 (Baldwin et al., , 1974a Baldwin, Glaves and Vose, 1974b) .
All of the tumours employed in the previous studies have been immunogenic, as defined by their capacity to elicit tumour rejection responses in syngeneic hosts. Other tumours, such as mammary carcinomata induced by 2-acetylaminofluorene (AAF) or arising spontaneously within the breeding population and also spontaneously developing sarcomata, are generally deficient or demonstrably lacking in tumour rejection antigens (Baldwin and Embleton, 1969a, b; . These, therefore, have been examined for tumour associated embryonic antigen to determine further whether this expression is a constant feature of malignant change and also whether these antigens are related to the tumour rejection antigens.
MATERIALS AND METHODS
Tumours -The tumours studied included mammary carcinomata and one ear duct carcinoma induced in female rats fed continuously on a diet containing 0.04%o w/w 2-acetylaminofluorene (Baldwin and Embleton, 1969a) . Spontaneously arising mammary carcinomata and sarcomata developed in breeding female rats between 179 and 565 days of age (Baldwin and Embleton, 1969b) . Tumours were passaged in syngeneic Wistar rats of the same sex as the primary host and early transplant generations were preserved in liquid nitrogen vapour. Their immunogenicity was determined by the tumour rejection response elicited in rats immunized by implantation of irradiated tumour grafts or by surgical excision of growing tumour against a challenge inoculum just sufficient to produce consistent tumour growth in controls. These characteristics have been published previously (Baldwin and Embleton, 1969a, b; Serum donors.-Serum was taken from rats having had more than 4 pregnancies and which were pregnant at the time of assay. Virgin female rats were used for controls and were generally age matched.
Tissue cultures-.Cell culture lines were initiated from single cell suspensions of trypsinized transplanted tumours and maintained by serial subculture in Waymouth's medium supplemented with 2000 foetal calf serum and antibiotics. They were used as a source of target cells for microcytotoxicity tests between the first and sixth passage.
Microcytotoxicity tests.-The complement dependent cytotoxicity of multiparous rat sera for plated target cells was assayed in Falcon Microtest plates (3034) as previously described (Baldwin et al., 1972b 
RESULTS

Microcytotoxicity tests
Embryonic antigens were detected at the surface of AAF induced mammary and ear duct carcinomata by the complement dependent cytotoxicity of sera from multiparous rats compared with that of virgin control sera (Table I ). All 4 tumours showed some significant reactivity with the sera, although the cytotoxicity was variable and generally low compared with that previously obtained with DAB induced hepatomata and Mc induced sarcomata (Baldwin et al., 1972b) . None of the sera used could be shown to have any reactivity against cells from adult liver, lung, diaphragm or kidney. (Table III) . Again the percentage cytotoxicity was generally low but significant when demonstrable and only a low proportion of the multiparous rat sera showed reactivity. Table IV summarizes tests with a larger panel of multiparous rat sera against these tumours. None of the sera used hepatomata (Baldwin et al., 1972a; 1974a by delayed hypersensitivity reactions (Wang, 1968) and by serological methods )05 using xenogeneic antisera raised against tumour and early embryo tissues (Thomembryonic antigens at the son and Alexander, 1973 Grant, Radisch and Wells, 1974) iogenic tumours was gener-or in vitro assays of cell mediated and iwever, both in the propor-humoral immune responses (Menard, Cal- Embryonic antigens on chemically induced tumours have generally proved to be cross-reactive (Baldwin et al., 1974a; Thomson and Alexander, 1973; Menard et al., 1973) . This is emphasized further by the data reported here showing that multiparous rat serum contains antibody reacting with cells of different tumour types, including sarcomata and mammary carcinomata. This does not exclude the possible expression of organ specific embryonic antigens on tumours since these serum donors may have been sensitized to a multiplicity of embryonic antigens during pregnancy. This is suggested by other studies (Baldwin and Embleton, 1974) where lymph node cells taken from rats bearing the essentially non-immunogenic mammary carcinomata employed in the present investigation were found to be cytotoxic in vitro for the autochthonous tumour and also other mammary carcinomata, but not histologically different tumour types. The neoantigens involved in these responses were viewed as being embryonic antigens since lymph node cell cytotoxicity could be blocked by treating target cells with multiparous rat serum. This, however, requires more direct evaluation since these conclusions are relevant to immunological studies of human malignant tissue where organ specific neoantigens have been identified (Hellstr6m and Hellstrom, 1973) . 
